Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography.
about
Molecular imaging in therapeutic efficacy assessment of targeted therapy for nonsmall cell lung cancerAntitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer CellsAn optical probe for noninvasive molecular imaging of orthotopic brain tumors overexpressing epidermal growth factor receptor.Imaging EGFR and HER2 by PET and SPECT: a review.Radionuclide imaging of drug delivery for patient selection in targeted therapy.PET of EGFR with (64) Cu-cetuximab-F(ab')2 in mice with head and neck squamous cell carcinoma xenografts.A purification system for (64)Cu produced by a biomedical cyclotron for antibody PET imaging.Evaluation of 99mTc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC.Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts.
P2860
Q34243500-8125CDAE-E1E8-4130-B584-FB2DA78BC392Q36482500-42E8C321-0809-48C8-AE36-D8956D0BC933Q37312780-3394FE38-79BE-4A31-AE6C-1BEB2C85D4A1Q38137829-45CF08C3-18DE-4153-B66E-5D055EBA698BQ38176652-4D8943A2-43FA-4963-B709-E22B0561BAB6Q38846349-E66E4E38-2995-45C6-BB83-DE49A607F9BBQ40679496-97A3BF8A-D7F7-409F-9CF5-5AD12E7F6C03Q41092700-A0DED15B-C4C5-4BF0-86E5-9344ACE70C82Q55508871-AD17B6B3-9309-47C2-B8AF-46A5267FDB95
P2860
Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Predicting cetuximab accumulat ...... positron emission tomography.
@en
Predicting cetuximab accumulat ...... positron emission tomography.
@nl
type
label
Predicting cetuximab accumulat ...... positron emission tomography.
@en
Predicting cetuximab accumulat ...... positron emission tomography.
@nl
prefLabel
Predicting cetuximab accumulat ...... positron emission tomography.
@en
Predicting cetuximab accumulat ...... positron emission tomography.
@nl
P2093
P2860
P1433
P1476
Predicting cetuximab accumulat ...... positron emission tomography.
@en
P2093
Arifudin Achmad
Hideyuki Tominaga
Hirofumi Hanaoka
Hiroki Yoshioka
Keigo Endo
Noboru Oriuchi
Shinji Yamamoto
Takuya Araki
Yasuhiro Ohshima
P2860
P304
P356
10.1111/J.1349-7006.2011.02166.X
P577
2011-12-23T00:00:00Z